Epidemiology of myelin oligodendrocyte glycoprotein antibody-associated disease: a review of prevalence and incidence worldwide
Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD) is an inflammatory demyelinating disease of the central nervous system (CNS) with the presence of conformation-sensitive antibodies against MOG. The spectrum of MOGAD includes monophasic/relapsing optic neuritis, myelitis,...
Main Authors: | Jyh Yung Hor, Kazuo Fujihara |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-09-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fneur.2023.1260358/full |
Similar Items
-
Human antibodies against the myelin oligodendrocyte glycoprotein can cause complement-dependent demyelination
by: Patrick Peschl, et al.
Published: (2017-10-01) -
Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-Associated Optic Neuritis – A Case Report and Literature Review
by: Nowacka B, et al.
Published: (2024-04-01) -
Myelin oligodendrocyte glycoprotein antibody-associated disease: a clinical analysis of 14 cases
by: DENG Bingmei, et al.
Published: (2024-06-01) -
Myelin Oligodendrocyte Glycoprotein-Antibody Associated Disease: An Updated Review of the Clinical Spectrum, Pathogenetic Mechanisms and Therapeutic Management
by: Panagiotis Gklinos, et al.
Published: (2024-05-01) -
Myelin Oligodendrocyte Glycoprotein: Deciphering a Target in Inflammatory Demyelinating Diseases
by: Patrick Peschl, et al.
Published: (2017-05-01)